Channel 42
Science is the answer to everything.

Study in journal Nature reveals atomic structure of enzyme capable of repelling HIV virus, suggesting new approach for drug development.

More: continued here

Researchers at McGill University, King’s College London and GlaxoSmithKline Inc. have identified two genetic variants in caucasians that together produce an astounding sevenfold increase the risk of male pattern baldness. Their results will be published Oct. 12 in the journal Nature Genetics.

More: continued here

Research results indicate that optical coherence tomography, a newly evolving imaging method, may be the best tool available to detect vulnerable plaque in coronary arteries. The findings will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics scientific symposium, sponsored by the Cardiovascular Research Foundation.

More: continued here

Results of five research studies and a clinical registry first-report presentation scheduled for the 20th annual Transcatheter Cardiovascular Therapeutics scientific symposium, sponsored by the Cardiovascular Research Foundation, suggest that triple antiplatelet therapy for patients undergoing percutaneous coronary intervention with drug-eluting stents achieves greater platelet inhibition than conventional dual antiplatelet therapy.

More: continued here

Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics scientific symposium, sponsored by the Cardiovascular Research Foundation, suggests that olmesartan, a drug commonly used to treat high blood pressure, may play a role in reducing coronary plaque.

More: continued here

Research results highlighting three new devices used to reduce blockages in peripheral and coronary arteries and to provide cardiac support will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics scientific symposium, sponsored by the Cardiovascular Research Foundation.

More: continued here

Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics scientific symposium, sponsored by the Cardiovascular Research Foundation, found that coronary heart disease symptoms presented in the context of a stressful life event were identified as psychogenic in origin when presented by women and organic in origin when presented by men. The study could help explain why there is often a delay in the assessment of women with heart disease.

More: continued here

A presentation on Oct. 12 at the INFORMS Annual Meeting will describe pandemic flu models that can help organizations improve their food distribution and school closing strategies in the event of such an emergency. The models are flexible so that multiple scenarios can be investigated to see which options meet an organization’s specific goal.

More: continued here

Nature Nanotechnology journal reveals how scientists from the London Center for Nanotechnology at UCL are using a nanotechnology to investigate the workings of vancomycin, one of the few antibiotics that can be used to combat increasingly resistant infections such as MRSA. The researchers, led by Rachel McKendry and Gabriel Aeppli, developed ultra-sensitive probes capable of providing new insight into how antibiotics work, paving the way for the development of more effective new drugs.

More: continued here

Scientists at Bonn and Düsseldorf Universities have discovered an important hair-loss gene. In 2005, these scientists had already characterized the first hair-loss gene inherited through the maternal line, which explained why hair-loss in men often reflects that of their maternal grandfathers. This newly discovered gene, on the other hand, may now account for the similarity in cranial hair growth between father and son.

More: continued here